STEPHANIE DOUD: Open Payments
NPI 1861128852 · DEER PARK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$890 in 26 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $890
Food & beverage: $890
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $196 |
| Lilly USA, LLC | 3 | $148 |
| ABBVIE INC. | 3 | $143 |
| Janssen Pharmaceuticals, Inc | 1 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Exact Sciences Corporation | 2 | $32 |
| Astellas Pharma US Inc | 1 | $25 |
| Philips North America LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $23 |
Products named: Wegovy, INVEGA SUSTENNA, LINZESS, ZEPBOUND, CAPLYTA, UBRELVY, Ozempic, The Cologuard Plus Collection Kit.
Industry payments across WA — which companies pay providers there.
